Over the past decade or so, patent portfolios have grown the way most strategic problems do quietly, incrementally, and largely unexamined. A product launches, filings follow. A new market opens, more filings follow. A competitor gets acquired, and suddenly the portfolio doubles. What doesn't grow at the same pace is the discipline of looking back at those decisions and asking whether they still make sense. Patents are often renewed automatically, following the routine of administrative processes rather than strategic reflection. Yet every renewal decision is in reality a new investment decision.
The real question that needs to be asked is whether the protection still serves the innovation strategy that originally justified it. The cost of ignoring this question can be substantial.
Protection can last up to twenty years, but the cost of maintaining it is heavily concentrated at the back end. Global patent cost analysis shows that 71% of total maintenance costs occur after the 10th year of protection, while the share reaches 88% in Germany, 80% in China and 83% in Korea. As in many jurisdictions the largest annuity increases occur around this stage of the lifecycle, with 28.13% of countries introducing more than 25% of fee increases.
So far, so manageable, if organizations were making active decisions about what to keep. But they're not. The global average patent lifetime sits at around fourteen years, and most companies wait more than thirteen of those years before pruning patents of questionable value. That means the most expensive years of a patent's life are also the years when it is least likely to have been examined.
Worldwide, companies are on track to spend more than $170 billion on patent renewal fees over the next two decades.
The gap between patent portfolios and business strategy rarely appears suddenly. It develops gradually as companies evolve. Technologies mature, product lines change direction and markets shift geographically.
A patent filed to protect an early research project may still be sitting in the portfolio long after the underlying technology has lost any relevance. Acquisitions introduce their own complications - patents that were valuable in a previous corporate context but no longer align with where the acquiring company is actually going.
When IP is managed primarily as a legal asset rather than a strategic one, that alignment weakens over time and portfolios become less coherent as a result.
A useful way to think about renewal decisions is to treat them as recurring investment decisions rather than administrative obligations. Renewal decisions effectively reflect how organisations evaluate the remaining value of their patents relative to the cost of maintaining them.
In practice, this means comparing the expected benefit the patent can still generate with the total renewal cost required to keep it in force for the rest of its term. Companies often approximate this by estimating the revenue linked to the protected technology or the strategic leverage the patent provides relative to the future maintenance cost of the patent family across jurisdictions.
Even patents that no longer protect active products may still deliver ROI if they support licensing negotiations or strengthen the company’s position in cross-licensing discussions. Framing renewals this way turns them into capital allocation decisions rather than routine administrative payments.
In practice, however, many renewal decisions are made without a structured evaluation of this kind. Some questions worth exploring before continuous renewal:
If the answer to these questions is unclear, renewal may simply preserve legal protection that no longer contributes to strategic objectives.
For this reason, many organizations are increasingly adopting systematic portfolio pruning processes. In a portfolio review of one mid-sized electronics company, 18% of patents turned out to have no identifiable commercial or strategic value. Pruning them reduced annual maintenance costs by more than $2 million.
Organizations that conduct structured portfolio reviews regularly reduce portfolio size by 20–30%, while strengthening the strategic focus of the remaining assets.
A smaller but more targeted portfolio allows organizations to concentrate legal, financial and managerial resources on patents that actively support their technologies, markets and competitive positioning.
You might be reading this and thinking: fine, but our portfolio is enormous, our renewal process is automated, and nobody has the bandwidth to review fourteen years of filings from scratch. Fair. But the answer isn't a one-time audit. It's changing how renewal decisions get made going forward.
The most practical starting point is linking patents directly to product architectures and technology roadmaps, so that when a product line is discontinued or a platform evolves, the associated IP gets flagged for review automatically rather than surviving on autopilot until the next payment is due.
Another emerging practice is the use of patent analytics to identify declining strategic relevance early. Citation patterns, competitor filing activity, and technology clustering can surface declining relevance before renewal costs peak, giving organizations time to make pruning decisions while there's still room to act.
Geographic alignment deserves its own audit. Companies routinely maintain patents in jurisdictions where they no longer manufacture, sell, or face any meaningful competitive pressure. Mapping active filings against actual market exposure tends to reveal more redundancy than most IP teams expect by exposing patents that no longer serve defensive or commercial purposes.
There is sometimes an assumption in IP circles that a large patent portfolio signals technological strength. Yet the strategic value of a portfolio depends less on its size than on its alignment with the company’s innovation priorities.
Portfolios don't become inefficient because companies file too many patents. They become inefficient because patents outlive the strategies that created them and nobody is accountable for asking the question. Not because anyone is doing anything wrong - but because the process was never designed to ask it.
A portfolio that genuinely reflects where a company competes, what it builds, and where its technology is headed can provide strong protection at a fraction of the cost of one that has simply never been examined.
Renewal decisions are not milestones to be processed. They are the recurring opportunity to answer something most organizations aren't currently asking: is what we're paying for still serving us?
That's a harder question than it sounds. But it's the right one to start with.
Sign up to receive alerts when we publish more blog posts about how NLPatent has brought success to the field of IP and AI.
.svg)
.png)
.svg){kind=small}
